QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
| |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) | |
|
| |
(Address of principal executive offices) |
(Zip Code) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
|
|
Nasdaq Global Select Market |
|
☒ |
Accelerated filer |
☐ | |||
Non-accelerated filer |
☐ |
Smaller reporting company |
| |||
Emerging growth company |
|
ITEM 1. |
||||||
3 |
||||||
4 |
||||||
5 |
||||||
6 |
||||||
7 |
||||||
ITEM 2. |
35 |
|||||
ITEM 3. |
46 |
|||||
ITEM 4. |
46 |
|||||
ITEM 1. |
46 |
|||||
ITEM 1A. |
47 |
|||||
ITEM 6. |
48 |
|||||
49 |
ITEM 1. | FINANCIAL STATEMENTS. |
June 30, 2019 |
December 31, 2018 |
|||||||
ASSETS |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | $ | ||||||
Short-term investments |
||||||||
Trade accounts receivable, net of allowance for doubtful accounts of $ |
||||||||
Inventories |
||||||||
Other current assets |
||||||||
Assets classified as held for sale |
— |
|||||||
Total current assets |
||||||||
Property, plant and equipment, net |
||||||||
Right-of-use asset |
— |
|||||||
Goodwill |
||||||||
Intangible assets, net |
||||||||
Long-term investments |
||||||||
Other assets |
||||||||
Total assets |
$ | $ | ||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY |
||||||||
Current liabilities: |
||||||||
Short-term debt |
$ | $ | ||||||
Accounts payable |
||||||||
Accrued compensation |
||||||||
Income taxes payable |
||||||||
Lease liability |
— |
|||||||
Deferred revenue and customer advances |
||||||||
Other current liabilities |
||||||||
Total current liabilities |
||||||||
Long-term debt, net |
||||||||
Non-current deferred taxes |
||||||||
Non-current accrued compensation |
||||||||
Non-current lease liability |
— |
|||||||
Other liabilities |
||||||||
Total liabilities |
||||||||
Commitments and contingencies (Note 19) |
||||||||
Stockholders’ equity: |
||||||||
Preferred Stock, $ |
— |
— |
||||||
Common Stock, |
||||||||
Additional paid-in capital |
||||||||
Retained earnings |
||||||||
Accumulated other comprehensive loss |
( |
) | ( |
) | ||||
Total stockholders’ equity |
||||||||
Total liabilities and stockholders’ equity |
$ | $ | ||||||
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
2019 |
2018 |
2019 |
2018 |
|||||||||||||
Net revenues: |
||||||||||||||||
Products |
$ | $ | $ | $ | ||||||||||||
Services |
||||||||||||||||
Total net revenues |
||||||||||||||||
Cost of revenues: |
||||||||||||||||
Cost of products |
||||||||||||||||
Cost of services |
||||||||||||||||
Total cost of revenues (exclusive of amortization shown separately below) |
||||||||||||||||
Gross profit |
||||||||||||||||
Research and development |
||||||||||||||||
Selling, general and administrative |
||||||||||||||||
Fees and expenses related to term loan |
— |
|||||||||||||||
Acquisition and integration costs |
( |
) | ( |
) | ||||||||||||
Restructuring and other |
||||||||||||||||
Amortization of intangible assets |
||||||||||||||||
Income from operations |
||||||||||||||||
Interest income |
||||||||||||||||
Interest expense |
||||||||||||||||
Other expense, net |
||||||||||||||||
Income before income taxes |
||||||||||||||||
Provision for income taxes |
||||||||||||||||
Net income |
$ | $ | $ | $ | ||||||||||||
Other comprehensive income: |
||||||||||||||||
Changes in value of financial instruments designated as cash flow hedges, net of tax (benefit) expense (1) |
$ | ( |
) | $ | $ | ( |
) | $ | ||||||||
Foreign currency translation adjustments, net of tax of $ |
( |
) | ( |
) | ( |
) | ||||||||||
Unrecognized pension gain (loss), net of tax (benefit) expense (2) |
( |
) | ||||||||||||||
Unrealized loss on investments, net of tax benefit (3) |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Total comprehensive income |
$ | $ | $ | $ | ||||||||||||
Net income per share: |
||||||||||||||||
Basic |
$ | $ | $ | $ | ||||||||||||
Diluted |
$ | $ | $ | $ | ||||||||||||
Weighted average common shares outstanding: |
||||||||||||||||
Basic |
||||||||||||||||
Diluted |
||||||||||||||||
(1) |
Tax (benefit) expense was $ ( and $( and $ |
(2) |
Tax (benefit) expense was $ ( and $( for the six months ended June 30, 2019 and 2018, respectively |
(3) |
Tax benefit was $ ( and $( for the three months ended June 30, 2019 and 2018, respectively. Tax benefit was $( and $( for the six months ended June 30, 2019 and 2018, respectively. |
Common Stock |
Additional Paid-In |
Retained |
Accumulated Other Comprehensive |
Total Stockholders’ |
||||||||||||||||||||
Shares |
Amount |
Capital |
Earnings |
Income/(Loss) |
Equity |
|||||||||||||||||||
Balance at December 31, 2018 |
|
$ | |
$ | |
$ | |
$ | ( |
) | $ | |
||||||||||||
Net issuance under stock-based plans |
|
|
|
|||||||||||||||||||||
Stock-based compensation |
|
|
||||||||||||||||||||||
Cash dividend ($ |
( |
) | ( |
) | ||||||||||||||||||||
Comprehensive income (net of tax): |
||||||||||||||||||||||||
Net income |
|
|
||||||||||||||||||||||
Other comprehensive loss |
( |
) | ( |
) | ||||||||||||||||||||
Balance at March 31, 2019 |
|
|
|
|
( |
) | |
|||||||||||||||||
Net issuance under stock-based plans |
|
( |
) | ( |
) | |||||||||||||||||||
Stock-based compensation |
|
|
||||||||||||||||||||||
Cash dividend ($ |
( |
) | ( |
) | ||||||||||||||||||||
Stock dividends accrued |
|
( |
) | — |
||||||||||||||||||||
Comprehensive income (net of tax): |
||||||||||||||||||||||||
Net income |
|
|
||||||||||||||||||||||
Other comprehensive loss |
( |
) | ( |
) | ||||||||||||||||||||
Balance at June 30, 2019 |
|
$ | |
$ | |
$ | |
$ | ( |
) | $ | |
||||||||||||
Common Stock |
Additional Paid-In |
Retained |
Accumulated Other Comprehensive |
Total Stockholders’ |
||||||||||||||||||||
Shares |
Amount |
Capital |
Earnings |
Income/(Loss) |
Equity |
|||||||||||||||||||
Balance at December 31, 2017 |
|
$ | |
$ | |
$ | |
$ | |
$ | |
|||||||||||||
Net issuance under stock-based plans |
|
( |
) | ( |
) | |||||||||||||||||||
Stock-based compensation |
|
|
||||||||||||||||||||||
Cash dividend ($ |
( |
) | ( |
) | ||||||||||||||||||||
Accounting Standards Codification Topic 606 adjustment |
|
|
||||||||||||||||||||||
Comprehensive income (net of tax): |
||||||||||||||||||||||||
Net income |
|
|
||||||||||||||||||||||
Other comprehensive gain |
|
|
||||||||||||||||||||||
Balance at March 31, 2018 |
|
|
|
|
|
|
||||||||||||||||||
Net issuance under stock-based plans |
|
( |
) | ( |
) | |||||||||||||||||||
Stock-based compensation |
|
|
||||||||||||||||||||||
Cash dividend ($ |
( |
) | ( |
) | ||||||||||||||||||||
Accounting Standards Codification Topic 606 adjustment |
( |
) | ( |
) | ||||||||||||||||||||
Comprehensive income (net of tax): |
||||||||||||||||||||||||
Net income |
|
|
||||||||||||||||||||||
Other comprehensive loss |
( |
) | ( |
) | ||||||||||||||||||||
Balance at June 30, 2018 |
|
$ | |
$ | |
$ | |
$ | |
$ | |
|||||||||||||
Six Months Ended June 30, |
||||||||
2019 |
2018 |
|||||||
Cash flows provided by operating activities: |
||||||||
Net income |
$ | |
$ | |
||||
Adjustments to reconcile net income to net cash provided by operating activities: |
||||||||
Depreciation and amortization |
|
|
||||||
Amortization of inventory step-up adjustment to fair value |
|
— |
||||||
Amortization of debt issuance costs, original issue discount, and soft call premium |
|
|
||||||
Stock-based compensation |
|
|
||||||
Provision for excess and obsolete inventory |
|
|
||||||
(Recovery) provision for doubtful accounts |
( |
) | |
|||||
Deferred income taxes |
( |
) | |
|||||
Other |
|
|
||||||
Changes in operating assets and liabilities, net of business acquired: |
||||||||
Trade accounts receivable |
|
( |
) | |||||
Inventories |
( |
) | ( |
) | ||||
Income taxes |
( |
) | ( |
) | ||||
Other current and non-current assets |
( |
) | ( |
) | ||||
Accrued compensation |
( |
) | ( |
) | ||||
Other current and non-current liabilities |
( |
) | |
|||||
Accounts payable |
( |
) | |
|||||
Net cash provided by operating activities |
|
|
||||||
Cash flows used in investing activities: |
||||||||
Acquisition of business, net of cash acquired |
( |
) | — |
|||||
Purchases of investments |
( |
) | ( |
) | ||||
Maturities of investments |
|
|
||||||
Sales of investments |
|
|
||||||
Proceeds from sale of assets |
|
— |
||||||
Purchases of property, plant and equipment |
( |
) | ( |
) | ||||
Net cash used in investing activities |
( |
) | ( |
) | ||||
Cash flows provided by (used in) financing activities: |
||||||||
Net proceeds from short and long-term borrowings |
|
|
||||||
Payments on short-term borrowings |
( |
) | ( |
) | ||||
Payments on long-term borrowings |
( |
) | ( |
) | ||||
Net payments related to employee stock awards |
( |
) | ( |
) | ||||
Dividend payments to common stockholders |
( |
) | ( |
) | ||||
Net cash provided by (used in) financing activities |
|
( |
) | |||||
Effect of exchange rate changes on cash and cash equivalents |
( |
) | |
|||||
(Decrease) Increase in cash and cash equivalents and restricted cash |
( |
) | |
|||||
Cash and cash equivalents at beginning of period |
|
|
||||||
Cash and cash equivalents at end of period |
$ | |
$ | |
||||
1) | Basis of Presentation |
2) | Recently Issued Accounting Pronouncements |
3) | Leases |
Three Months Ended June 30, 2019 |
|
Six Months Ended June 30, 2019 |
| |||||
Lease Cost: |
|
|
|
| ||||
Operating lease cost |
$ | |
|
$ |
|
|
|
|
Amount |
| |
Year Ending December 31, |
|
|
| |
2019 (remaining) |
$ | |
||
2020 |
|
|||
2021 |
|
|||
2022 |
|
|||
2023 |
|
|||
Thereafter |
|
|||
Total lease payments |
|
|||
Less: imputed interest |
|
|||
Total operating lease liabilities |
$ | |
||
|
Operating Leases |
|||
Year Ending December 31, |
|
|
|
|
2019 |
$ | |
||
2020 |
|
|||
2021 |
|
|||
2022 |
|
|||
2023 |
|
|||
Thereafter |
|
|||
Total minimum lease payments |
$ | |
||
4) | Revenue from Contracts with Customers |
Contract assets as of June 30, 2019 and December 31, 2018 were $ |
Six Months Ended June 30, 2019 |
||||
Beginning balance, January 1 (1) |
$ | |
||
Deferred revenue and customer advances assumed in ESI Merger |
|
|||
Additions to deferred revenue and customer advances |
|
|||
Amount of deferred revenue and customer advances recognized in income |
( |
) | ||
Ending balance, June 30 (2) |
$ | |
||
(1) |
Beginning deferred revenue and customer advances as of January 1, 2019 included $ |
(2) |
Ending deferred revenue as of June 30, 2019 included $ |
Three Months Ended June 30, 2019 |
||||||||||||||||
Vacuum & Analysis |
Light & Motion |
Equipment & Solutions |
Total |
|||||||||||||
Net revenues: |
||||||||||||||||
Products |
$ | |
$ | |
$ | |
$ | |
||||||||
Services |
|
|
|
|
||||||||||||
Total net revenues |
$ | |
$ | |
$ | |
$ | |
||||||||
Three Months Ended June 30, 2018 |
||||||||||||||||
Vacuum & Analysis |
Light & Motion |
Equipment & Solutions |
Total |
|||||||||||||
Net revenues: |
||||||||||||||||
Products |
$ | |
$ | |
$ | — |
$ | |
||||||||
Services |
|
|
— |
|
||||||||||||
Total net revenues |
$ | |
$ | |
$ | — |
$ | |
||||||||
Six Months Ended June 30, 2019 |
||||||||||||||||
Vacuum & Analysis |
Light & Motion |
Equipment & Solutions |
Total |
|||||||||||||
Net revenues: |
||||||||||||||||
Products |
$ | |
$ | |
$ | |
$ | |
||||||||
Services |
|
|
|
|
||||||||||||
Total net revenues |
$ | |
$ | |
$ | |
$ | |
||||||||
Six Months Ended June 30, 2018 |
||||||||||||||||
Vacuum & Analysis |
Light & Motion |
Equipment & Solutions |
Total |
|||||||||||||
Net revenues: |
||||||||||||||||
Products |
$ | |
|
$ | — |
$ | |
|||||||||
Services |
|
|
— |
|
||||||||||||
Total net revenues |
$ | |
$ | |
$ | — |
$ | |
||||||||
5) | Investments |
June 30, 2019 |
December 31, 2018 |
|||||||
Available-for-sale investments: |
||||||||
Time deposits and certificates of deposit |
$ | |
$ | |
||||
Bankers’ acceptance drafts |
|
|
||||||
Asset-backed securities |
— |
|
||||||
Commercial paper |
|
|
||||||
Corporate obligations |
|
|
||||||
U.S. treasury obligations |
— |
|
||||||
U.S. agency obligations |
|
|
||||||
$ | |
$ | |
|||||
June 30, 2019 |
December 31, 2018 |
|||||||
Available-for-sale investments: |
||||||||
Group insurance contracts |
$ | |
$ | |
||||
Cost method investments: |
||||||||
Minority interest in a private company |
|
|
||||||
$ | |
$ | |
|||||
As of June 30, 2019: |
Cost |
Gross Unrealized Gains |
Gross Unrealized (Losses) |
Estimated Fair Value |
||||||||||||
Short-term investments: |
||||||||||||||||
Available-for-sale investments: |
||||||||||||||||
Time deposits and certificates of deposit |
$ | |
$ | |
$ | — |
$ | |
||||||||
Bankers’ acceptance drafts |
|
— |
— |
|
||||||||||||
Commercial paper |
|
— |
( |
) | |
|||||||||||
Corporate obligations |
|
|
— |
|
||||||||||||
U.S. agency obligations |
|
|
( |
) | |
|||||||||||
$ | |
$ | |
$ | ( |
) | $ | |
||||||||
As of June 30, 2019: |
Cost |
Gross Unrealized Gains |
Gross Unrealized (Losses) |
Estimated Fair Value |
||||||||||||
Long-term investments: |
||||||||||||||||
Available-for-sale investments: |
||||||||||||||||
Group insurance contracts |
$ | |
$ | |
$ | |
$ | |
||||||||
As of December 31, 2018: |
Cost |
Gross Unrealized Gains |
Gross Unrealized (Losses) |
Estimated Fair Value |
||||||||||||
Short-term investments: |
||||||||||||||||
Available-for-sale investments: |
||||||||||||||||
Time deposits and certificates of deposit |
$ | |
$ | — |
$ | — |
$ | |
||||||||
Bankers’ acceptance drafts |
|
— |
— |
|
||||||||||||
Asset-backed securities |
|
|
( |
) | |
|||||||||||
Commercial paper |
|
— |
( |
) | |
|||||||||||
Corporate obligations |
|
— |
( |
) | |
|||||||||||
U.S. treasury obligations |
|
|
— |
|
||||||||||||
U.S. agency obligations |
|
|
( |
) | |
|||||||||||
$ | |
$ | |
$ | ( |
) | $ | |
||||||||
As of December 31, 2018: |
Cost |
Gross Unrealized Gains |
Gross Unrealized (Losses) |
Estimated Fair Value |
||||||||||||
Long-term investments: |
||||||||||||||||
Available-for-sale investments: |
||||||||||||||||
Group insurance contracts |
$ | |
$ | |
$ | — |
$ | |
||||||||
In accordance with the provisions of fair value accounting, a fair value measurement assumes that the transaction to sell an asset or transfer a liability occurs in the principal market for the asset or liability or, in the absence of a principal market, the most advantageous market for the asset or liability and defines fair value based upon an exit price model. |
Level 1 | Quoted prices in active markets for identical assets or liabilities assessed as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. |
Level 2 | Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 2 assets and liabilities include debt securities with quoted prices that are traded less frequently than exchange-traded instruments or securities or derivative contracts that are valued using a pricing model with inputs that are observable in the market or can be derived principally from or corroborated by observable market data. |
Level 3 | Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation. |
Fair Value Measurements at Reporting Date Using |
||||||||||||||||
Description |
June 30, 2019 |
Quoted Prices in Active Markets for Identical Assets or Liabilities (Level 1) |
Significant Other Observable Inputs (Level 2) |
Significant Unobservable Inputs (Level 3) |
||||||||||||
Assets: |
||||||||||||||||
Cash equivalents: |
||||||||||||||||
Money market funds |
$ | |
$ | |
$ | — |
$ | — |
||||||||
Time deposits and certificates of deposit |
|
— |
|
— |
||||||||||||
Commercial paper |
|
— |
|
— |
||||||||||||
U.S. agency obligations |
|
— |
|
— |
||||||||||||
Restricted cash – money market funds |
|
|
— |
— |
||||||||||||
Available-for-sale investments: |
||||||||||||||||
Time deposits and certificates of deposit |
|
— |
|
— |
||||||||||||
Bankers’ acceptance drafts |
|
— |
|
— |
||||||||||||
Commercial paper |
|
— |
|
— |
||||||||||||
Corporate obligations |
|
— |
|
— |
||||||||||||
U.S. agency obligations |
|
|
|
|
|
|
— |
|
|
|
|
|
|
— | | |
Group insurance contracts |
|
— |
|
— |
||||||||||||
Derivatives – currency forward contracts |
|
— |
|
— |
||||||||||||
Funds in investments and other assets: |
||||||||||||||||
Israeli pension assets |
|
— |
|
— |
||||||||||||
Deferred compensation plan assets: |
||||||||||||||||
Mutual funds and exchange traded funds |
|
— |
|
— |
||||||||||||
Money market securities |
|
— |
|
— |
||||||||||||
Total assets |
$ | |
$ | |
$ | |
$ | — |
||||||||
Liabilities: |
||||||||||||||||
Derivatives – currency forward contracts |
$ | |
$ | — |
$ | |
$ | — |
||||||||
Derivatives – interest rate hedge – non-current |
|
|
|
|
|
|
— |
|
|
|
|
|
|
|
— |
|
Total liabilities |
|
$ |
|
|
|
$ |
— |
|
|
$ |
|
|
|
$ |
— |
|
Reported as follows: |
||||||||||||||||
Assets: |
||||||||||||||||
Cash and cash equivalents, including restricted cash (1) |
$ | |
$ | |
$ | |
$ | — |
||||||||
Short-term investments |
|
— |
|
— |
||||||||||||
Other current assets |
|
— |
|
— |
||||||||||||
Total current assets |
$ | |
$ | |
$ | |
$ | — |
||||||||
Long-term investments (2) |
$ | |
$ | — |
$ | |
$ | — |
||||||||
Other assets |
|
— |
|
— |
||||||||||||
Total long-term assets |
$ | |
$ | — |
$ | |
$ | — |
||||||||
Liabilities: |
||||||||||||||||
Other current liabilities |
$ | |
$ | — |
$ | |
$ | — |
||||||||
Other liabilities |
|
$ |
|
|
|
$ |
— |
|
|
$ |
|
|
|
$ |
— |
|
(1) |
The cash and cash equivalent amounts presented in the table above do not include cash of $ |
(2) |
The long-term investments presented in the table above do not include the Company’s minority interest investment in a private company, which is accounted for under the cost method. |
Fair Value Measurements at Reporting Date Using |
||||||||||||||||
Description |
December 31, 2018 |
Quoted Prices in Active Markets for Identical Assets or Liabilities (Level 1) |
Significant Other Observable Inputs (Level 2) |
Significant Unobservable Inputs (Level 3) |
||||||||||||
Assets: |
||||||||||||||||
Cash equivalents: |
||||||||||||||||
Money market funds |
$ | |
$ | |
$ | — |
$ | — |
||||||||
Time deposits and certificates of deposit |
|
— |
|
— |
||||||||||||
Commercial paper |
|
— |
|
— |
||||||||||||
U.S. agency obligations |
|
— |
|
— |
||||||||||||
Restricted cash – money market funds |
|
|
— |
— |
||||||||||||
Available-for-sale investments: |
||||||||||||||||
Time deposits and certificates of deposit |
|
— |
|
— |
||||||||||||
Bankers’ acceptance drafts |
|
— |
|
— |
||||||||||||
Asset-backed securities |
|
— |
|
— |
||||||||||||
Commercial paper |
|
— |
|
— |
||||||||||||
Corporate obligations |
|
— |
|
— |
||||||||||||
U.S. treasury obligations |
|
— |
|
— |
||||||||||||
U.S. agency obligations |
|
— |
|
— |
||||||||||||
Group insurance contracts |
|
— |
|
— |
||||||||||||
Derivatives – currency forward contracts |
|
— |
|
— |
||||||||||||
Funds in investments and other assets: |
||||||||||||||||
Israeli pension assets |
|
— |
|
— |
||||||||||||
Derivatives – interest rate hedge – non-current |
|
— |
|
— |
||||||||||||
Total assets |
$ | |
$ | |
$ | |
$ | — |
||||||||
Liabilities: |
||||||||||||||||
Derivatives – currency forward contracts |
$ | |
$ | — |
$ | |
$ | — |
||||||||
Reported as follows: |
||||||||||||||||
Assets: |
||||||||||||||||
Cash and cash equivalents, including restricted cash (1) |
$ | |
$ | |
$ | |
$ | — |
||||||||
Short-term investments |
|
— |
|
— |
||||||||||||
Other current assets |
|
— |
|
— |
||||||||||||
Total current assets |
$ | |
$ | |
$ | |
$ | — |
||||||||
Long-term investments (2) |
$ | |
$ | — |
$ | |
$ | — |
||||||||
Other assets |
|
— |
|
— |
||||||||||||
Total long-term assets |
$ | |
$ | — |
$ | |
$ | — |
||||||||
Liabilities: |
||||||||||||||||
Other current liabilities |
$ | |
$ | — |
$ | |
$ | — |
||||||||
(1) |
The cash and cash equivalent amounts presented in the table above do not include cash of $ |
(2) |
The long-term investments presented in the table above do not include the Company’s minority interest investment in a private company, which is accounted for under the cost method. |
7) | Derivatives |
June 30, 2019 |
||||||||
Currency Hedged (Buy/Sell) |
Gross Notional Value |
Fair Value (1) |
||||||
U.S. Dollar/Japanese Yen |
$ | $ | ( |
) | ||||
U.S. Dollar/South Korean Won |
||||||||
U.S. Dollar/Euro |
||||||||
U.S. Dollar/U.K. Pound Sterling |
||||||||
U.S. Dollar/Taiwan Dollar |
||||||||
Total |
$ | $ | ||||||
December 31, 2018 |
||||||||
Currency Hedged (Buy/Sell) |
Gross Notional Value |
Fair Value (1) |
||||||
U.S. Dollar/Japanese Yen |
$ | $ | ( |
) | ||||
U.S. Dollar/South Korean Won |
||||||||
U.S. Dollar/Euro |
||||||||
U.S. Dollar/U.K. Pound Sterling |
||||||||
U.S. Dollar/Taiwan Dollar |
||||||||
Total |
$ | $ | ||||||
(1) |
Represents the receivable (payable) amount included in the consolidated balance sheet. |
June 30, 2019 |
December 31, 2018 |
|||||||
Derivative assets: |
||||||||
Foreign exchange contracts (1) |
$ | $ | ||||||
Interest rate hedge (2) |
— |
|||||||
Derivative liabilities: |
||||||||
Foreign exchange contracts (1) |
( |
) | ( |
) | ||||
Interest rate hedge (2) |
( |
) |
— |
|||||
Total net derivative (liability) asset designated as hedging instruments |
$ | ( |
) | $ | ||||
(1) |
The derivative assets of $ |
(2) |
The interest rate hedge liability of $ |
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
Derivatives Designated as Cash Flow Hedging Instruments |
2019 |
2018 |
2019 |
2018 |
||||||||||||
Forward exchange contracts: |
||||||||||||||||
Net gain (loss) recognized in OCI (1) |
$ | ( |
) | $ | |
$ | ( |
) | $ | |
||||||
Net gain (loss) reclassified from accumulated OCI into income (2) |
$ | |
$ | ( |
) | $ | |
$ | ( |
) |
(1) |
Net change in the fair value of the effective portion classified in OCI. |
|
|
(2) |
Effective portion classified in cost of products for the three and six months ended June 30, 2019 and 2018. The tax effect of the gains or losses reclassified from accumulated OCI into income is immaterial. |
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
Derivatives Not Designated as Hedging Instruments |
2019 |
2018 |
2019 |
2018 |
||||||||||||
Forward exchange contracts: |
||||||||||||||||
Net gain (loss) recognized in income (1) |
$ | ( |
) | $ | |
$ | ( |
) | $ | |
(1) |
The Company enters into foreign exchange contracts to hedge against changes in the balance sheet for certain subsidiaries to mitigate the risk associated with certain foreign currency transactions in the ordinary course of business. These derivatives are not designated as hedging instruments and gains or losses from these derivatives are recorded immediately in other (expense) income. |
8) | Inventories |
June 30, 2019 |
December 31, 2018 |
|||||||
Raw materials |
$ | |
$ | |
||||
Work-in-process |
|
|
||||||
Finished goods |
|
|
||||||
$ | |
$ | |
|||||
9) | Acquisitions |
Cash paid for outstanding shares (1) |
$ | |
||
Settlement of share-based compensation awards (2) |
|
|||
Total purchase price |
|
|||
Less: Cash and cash equivalents acquired |
( |
) | ||
Total purchase price, net of cash and cash equivalents acquired |
$ | |
||
(1) |
Represents cash paid of $ |
|
|
(2) |
Represents the vested but not issued portion of ESI share-based compensation awards as of the acquisition date of February 1, 2019. |
Current assets (excluding inventory) |
$ | |
||
Inventory |
|
|||
Intangible assets |
|
|||
Goodwill |
|
|||
Property, plant and equipment |
|
|||
Long-term assets |
|
|||
Total assets acquired |
|
|||
Current liabilities |
|
|||
Non-current deferred taxes |
|
|||
Other long-term liabilities |
|
|||
Total liabilities assumed |
|
|||
Fair value of assets acquired and liabilities assumed |
|
|||
Less: Cash and cash equivalents acquired |
( |
) | ||
Total purchase price, net of cash and cash equivalents acquired |
$ | |
||
Completed technology - Laser |
$ | |
||
Completed technology - Non-Laser |
|
|||
Trademarks and trade names |
|
|||
Customer relationships |
|
|||
Backlog |
|
|||
$ | |
|||
Three Months Ended June 30, 2019 |
Six Months Ended June 30, 2019 |
|||||||
Total net revenues |
$ | |
$ | |
||||
Net loss |
$ | ( |
) | $ | ( |
) | ||
Net loss per share: |
||||||||
Basic |
$ | ( |
) | $ | ( |
) | ||
Diluted |
$ | ( |
) | $ | ( |
) | ||
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
2019 |
2018 |
2019 |
2018 |
|||||||||||||
Total net revenues |
$ | |
$ | $ | |
$ | |
|||||||||
Net income |
$ | |
$ | |
$ | |
$ | |
||||||||
Net income per share: |
||||||||||||||||
Basic |
$ | |
$ | |
$ | |
$ | |
||||||||
Diluted |
$ | |
$ | |
$ | |
$ | |
||||||||
(1) | Incremental amortization and depreciation expense related to the estimated fair value of identifiable intangible assets and property, plant and equipment, respectively, from the purchase price allocation. |
(2) | Revenue and cost of goods sold adjustments as a result of the reduction in deferred revenue and the cost related to their estimated fair value. |
(3) | Incremental interest expense related to the Company’s 2019 Incremental Term Loan Facility, as defined and discussed in Note 11. |
(4) | The exclusion of acquisition costs and inventory step-up amortization from the three and six month period ended June 30, 2019 and the addition of these items to the three and six month period ended June 30, 2018. |
(5) | The exclusion of debt issuance costs due to the modification of the 2019 Incremental Term Loan Facility from the three and six month period ended June 30, 2019 and the addition of this item to the three and six month period ended June 30, 2018. |
(6) | The estimated tax impact of the above adjustments. |
10) | Goodwill and Intangible Assets |
Six Months Ended June 30, 2019 |
Twelve Months Ended December 31, 2018 |
|||||||||||||||||||||||
Gross Carrying Amount |
Accumulated Impairment Loss |
Net |
Gross Carrying Amount |
Accumulated Impairment Loss |
Net |
|||||||||||||||||||
Beginning balance at January 1 |
$ | $ | ( |
) | $ | 586,996 |
$ | $ | ( |
) | $ | |||||||||||||
Acquired goodwill (1) |
472,695 |
— |
||||||||||||||||||||||
Foreign currency translation |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||
Ending balance at June 30, 2019 and December 31, 2018 |
$ | $ | ( |
) | $ | 1,058,667 |
$ | $ | ( |
) | $ | 586,996 |
||||||||||||
(1) |
During the six months ended June 30, 2019, the Company recorded $ |
As of June 30, 2019: |
Gross |
Accumulated Impairment Charges |
Accumulated Amortization |
Foreign Currency Translation |
Net |
|||||||||||||||
Completed technology (1) |
$ | $ | ( |
) | $ | ( |
) | $ | ( |
) | $ | |||||||||
Customer relationships (1) |
( |
) | ( |
) | ( |
) | ||||||||||||||
Patents, trademarks, trade names and other (1) |
( |
) | ||||||||||||||||||
$ | $ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ||||||||||
(1) |
During the six months ended June 30, 2019, the Company recorded $ right-of-use asset line in the balance sheet. |
As of December 31, 2018: |
Gross |
Accumulated Impairment Charges |
Accumulated Amortization |
Foreign Currency Translation |
Net |
|||||||||||||||
Completed technology |
$ | $ | ( |
) | $ | ( |
) | $ | ( |
) | $ | |||||||||
Customer relationships |
( |
) | ( |
) | ( |
) | ||||||||||||||
Patents, trademarks, trade names and other |
( |
) | ( |
) | ||||||||||||||||
$ | $ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ||||||||||
Year |
Amount |
|||
2019 (remaining) |
$ | |||
2020 |
||||
2021 |
||||
2022 |
||||
2023 |
||||
2024 |
||||
Thereafter |
11) | Debt |
June 30, 2019 |
December 31, 2018 |
|||||||
Short-term debt: |
||||||||
Japanese lines of credit |
$ | |
$ | |
||||
Japanese receivables financing facility |
|
|
||||||
Other debt |
|
|
||||||
Term Loan Facility |
|
|
||||||
$ | |
$ | |
|||||
June 30, 2019 |
December 31, 2018 |
|||||||
Long-term debt: |
||||||||
Other debt |
$ | |
$ | |
||||
Term Loan Facility, net (1) |
|
|
||||||
$ | |
$ | |
|||||
(1) |
Net of deferred financing fees, original issuance discount and repricing fee of $ |
Year |
Amount |
|||
2019 (remaining) |
$ | |
||
2020 |
|
|||
2021 |
|
|||
2022 |
|
|||
2023 |
|
|||
2024 |
|
|||
Thereafter |
|
12) | Product Warranties |
Six Months Ended June 30, |
||||||||
2019 |
2018 |
|||||||
Beginning of period |
$ | |
$ | |
||||
Assumed product warranty liability from ESI Merger |
|
— |
||||||
Provision for product warranties |
|
|
||||||
Direct and other charges to warranty liability |
( |
) | ( |
) | ||||
End of period (1) |
$ | |
$ | |
||||
(1) |
As of June 30, 2019, short-term product warranty of $ |
13) | Income Taxes |
14) | Net Income Per Share |
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
2019 |
2018 |
2019 |
2018 |
|||||||||||||
Numerator: |
||||||||||||||||
Net income |
$ | |
$ | |
$ | |
$ | |
||||||||
Denominator: |
||||||||||||||||
Shares used in net income per common share – basic |
54,815,000 |
54,719,000 |
54,481,000 |
54,571,000 |
||||||||||||
Effect of dilutive securities: |
||||||||||||||||
Restricted stock units, stock appreciation rights and shares issued under employee stock purchase plan |
|
|
|
|
||||||||||||
Shares used in net income per common share – diluted |
55,089,000 |
55,274,000 |
54,966,000 |
55,280,000 |
||||||||||||
Net income per common share: |
||||||||||||||||
Basic |
$ | |
$ | |
$ | |
$ | |
||||||||
Diluted |
$ | |
$ | |
$ | |
$ | |
15) | Stock-Based Compensation |
• | all RSUs that vest based solely on the satisfaction of service conditions, granted under any ESI equity plan, arrangement or agreement (“ESI Plan”) that were outstanding immediately prior to the effective time of the ESI Merger, and as to which shares of ESI common stock were not fully distributed in connection with the closing of the ESI Merger, |
• | all RSUs that were granted subject to vesting based on both the achievement of performance goals and the satisfaction of service conditions granted under any ESI Plan that were outstanding immediately prior to the effective time of the ESI Merger, and |
• | all SARs granted under any ESI Plan, whether vested or unvested, that were outstanding immediately prior to the effective time of the ESI Merger and held by an individual who was a service provider of ESI as of the date on which the effective time of the ESI Merger occurred. |
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
2019 |
2018 |
2019 |
2018 |
|||||||||||||
Cost of revenues |
$ | |
$ | |
$ | |
$ | |
||||||||
Research and development expense |
|
|
|
|
||||||||||||
Selling, general and administrative expense |
|
|
|
|
||||||||||||
Acquisition and integration related expense |
|
— |
|
— |
||||||||||||
Total pre-tax stock-based compensation expense |
$ | |
$ | |
$ | |
$ | |
||||||||
Six Months Ended June 30, 2019 |
||||||||
Outstanding RSUs |
Weighted Average Grant Date Fair Value |
|||||||
RSUs – beginning of period |
|
$ | |
|||||
Assumed shares from ESI Merger |
|
$ | |
|||||
Accrued dividend shares |
|
$ | |
|||||
Granted |
|
$ | |
|||||
Vested |
( |
) | $ | |
||||
Forfeited |
( |
) | $ | |
||||
RSUs – end of period |
|
$ | |
|||||
Six Months Ended June 30, 2019 |
||||||||
Outstanding SARs |
Weighted Average Grant Date Fair Value |
|||||||
SARs – beginning of period |
|
$ | |
|||||
Assumed SARs from ESI Merger |
|
$ | |
|||||
Exercised |
( |
) | $ | |
||||
Forfeited or expired |
( |
) | $ | |
||||
SARs Outstanding – end of period |
|
$ | |
|||||
16) | Stockholders’ Equity |
17) | Business Segment, Geographic Area, Product and Significant Customer Information |
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
2019 |
2018 |
2019 |
2018 |
|||||||||||||
Vacuum & Analysis |
$ | $ | $ | $ | ||||||||||||
Light & Motion |
||||||||||||||||
Equipment & Solutions |
— |
— |
||||||||||||||
$ | $ | $ | $ | |||||||||||||
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
2019 |
2018 |
2019 |
2018 |
|||||||||||||
Gross profit by reportable segment: |
||||||||||||||||
Vacuum & Analysis |
$ | $ | $ | $ | ||||||||||||
Light & Motion |
||||||||||||||||
Equipment & Solutions |
— |
|||||||||||||||
Total gross profit by reportable segment |
||||||||||||||||
Operating expenses: |
||||||||||||||||
Research and development |
||||||||||||||||
Selling, general and administrative |
||||||||||||||||
Fees and expenses related to term loan |
— |
|||||||||||||||
Acquisition and integration costs |
( |
) | ( |
) | ||||||||||||
Restructuring and other |
||||||||||||||||
Amortization of intangible assets |
||||||||||||||||
Income from operations |
||||||||||||||||
Interest and other expense, net |
||||||||||||||||
Income before income taxes |
||||||||||||||||
Provision for income taxes |
||||||||||||||||
Net income |
$ | $ | $ | $ | ||||||||||||
Vacuum & Analysis |
Light & Motion |
Equipment & Solutions |
Total |
|||||||||||||
Three Months Ended June 30, 2019: |
||||||||||||||||
Capital expenditures |
$ | $ | $ | $ | ||||||||||||
Six Months Ended June 30, 2019: |
||||||||||||||||
Capital expenditures |
$ | $ | $ | $ | ||||||||||||
Three Months Ended June 30, 2018: |
||||||||||||||||
Capital expenditures |
$ | $ | $ | — |
$ | |||||||||||
Six Months Ended June 30, 2018: |
||||||||||||||||
Capital expenditures |
$ | $ | $ | — |
$ | |||||||||||
Vacuum & Analysis |
Light & Motion |
Equipment & Solutions |
Total |
|||||||||||||
Three Months Ended June 30, 2019: |
||||||||||||||||
Depreciation and amortization |
$ | |
$ | |
$ | |
$ | |
||||||||
Six Months Ended June 30, 2019 |
||||||||||||||||
Depreciation and amortization |
$ | |
$ | |
$ | |
$ | |
||||||||
Three Months Ended June 30, 2018: |
||||||||||||||||
Depreciation and amortization |
$ | |
$ | |
$ | — |
$ | |
||||||||
Six Months Ended June 30, 2018: |
||||||||||||||||
Depreciation and amortization |
$ | |
$ | |
$ | — |
$ | |
||||||||
June 30, 2019: |
Vacuum & Analysis |
Light & Motion |
Equipment & Solutions |
Corporate, Eliminations & Other |
Total |
|||||||||||||||
Segment assets: |
||||||||||||||||||||
Trade accounts receivable |
$ | |
$ | |
$ | |
$ | ( |
) | $ | |
|||||||||
Inventories |
|
|
|
( |
) | |
||||||||||||||
Total segment assets |
$ | |
$ | |
$ | |
$ | ( |
) | $ | |
|||||||||
December 31, 2018: |
Vacuum & Analysis |
Light & Motion |
Equipment & Solutions |
Corporate, Eliminations & Other |
Total |
|||||||||||||||
Segment assets: |
||||||||||||||||||||
Trade accounts receivable |
$ | |
$ | |
$ | — |
$ | ( |
) | $ | |
|||||||||
Inventories |
|
|
— |
|
|
|||||||||||||||
Total segment assets |
$ | |
$ | |
$ | — |
$ | ( |
) | $ | |
|||||||||
June 30, 2019 |
December 31, 2018 |
|||||||
Total segment assets |
$ | |
$ | |
||||
Cash and cash equivalents and investments |
|
|
||||||
Other current assets |
|
|
||||||
Assets classified as held for sale |
|
|
|
|
|
|
— |
|
Property, plant and equipment, net |
|
|
||||||
Right-of-use asset |
|
— |
||||||
Goodwill and intangible assets, net |
|
|
||||||
Other assets |
|
|
||||||
Consolidated total assets |
$ | |
$ | |
||||
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
2019 |
2018 |
2019 |
2018 |
|||||||||||||
Net revenues: |
||||||||||||||||
United States |
$ | |
$ | |
$ | |
$ | |
||||||||
China |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Korea |
|
|
|
|
||||||||||||
Japan |
|
|
|
|
||||||||||||
Other Asia |
|
|
|
|
||||||||||||
Europe |
|
|
|
|
||||||||||||
$ | |
$ | |
$ | |
$ | |
|||||||||
June 30, 2019 |
December 31, 2018 |
|||||||
Long-lived assets: (1) |
||||||||
United States |
$ | |
$ | |
||||
Europe |
|
|
||||||
Asia |
|
|
||||||
$ | |
$ | |
|||||
(1) |
Long-lived assets include property, plant and equipment, net and certain other long-term assets, excluding long-term tax related accounts. |
June 30, 2019 |
December 31, 2018 |
|||||||
Reportable segment: |
||||||||
Vacuum & Analysis |
$ | |
$ | |
||||
Light & Motion |
|
|
||||||
Equipment & Solutions |
|
— |
||||||
Total goodwill |
$ | 1,058,667 |
$ | 586,996 |
||||
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
2019 |
2018 |
2019 |
2018 |
|||||||||||||
Advanced Manufacturing Components |
$ | |
$ | |
$ | |
$ | |
||||||||
Global Service |
|
|
|
|
||||||||||||
Advanced Manufacturing Systems |
|
— |
|
— |
||||||||||||
$ | |
$ | |
$ | |
$ | |
|||||||||
18) | Restructuring and Other |
Six Months Ended June 30, |
||||||||
2019 |
2018 |
|||||||
Beginning of period restructuring accrual |
$ | |
$ | |
||||
Charged to expense |
|
|
||||||
Payments and adjustments |
( |
) | ( |
) | ||||
End of period restructuring accrual |
$ | |
$ | |
||||
19) | Commitments and Contingencies |
20) | Assets Classified as Held for Sale |
ITEM 2. | MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. |
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
2019 |
2018 |
2019 |
2018 |
|||||||||||||
Net revenues: |
||||||||||||||||
Product |
84.7 |
% | 89.0 |
% | 85.2 |
% | 89.3 |
% | ||||||||
Services |
15.3 |
11.0 |
14.8 |
10.7 |
||||||||||||
Total net revenues |
100.0 |
100.0 |
100.0 |
100.0 |
||||||||||||
Cost of revenues: |
||||||||||||||||
Cost of product revenues |
47.7 |
46.5 |
48.6 |
46.8 |
||||||||||||
Cost of service revenues |
7.8 |
5.5 |
7.8 |
5.5 |
||||||||||||
Total cost of revenues (exclusive of amortization shown separately below) |
55.5 |
52.0 |
56.4 |
52.3 |
||||||||||||
Gross profit |
44.5 |
48.0 |
43.6 |
47.7 |
||||||||||||
Research and development |
8.8 |
6.4 |
8.6 |
6.3 |
||||||||||||
Selling, general and administrative |
17.6 |
13.4 |
17.7 |
14.1 |
||||||||||||
Fees and expenses related to term loan |
— |
— |
0.6 |
— |
||||||||||||
Acquisition and integration costs |
0.7 |
(0.2 |
) | 3.5 |
(0.1 |
) | ||||||||||
Restructuring and other |
0.2 |
0.1 |
0.3 |
0.3 |
||||||||||||
Amortization of intangible assets |
3.7 |
1.9 |
3.6 |
2.0 |
||||||||||||
Income from operations |
13.5 |
26.4 |
9.3 |
25.1 |
||||||||||||
Interest income |
0.3 |
0.3 |
0.3 |
0.2 |
||||||||||||
Interest expense |
2.7 |
0.7 |
2.3 |
0.8 |
||||||||||||
Other expense, net |
0.1 |
0.1 |
0.1 |
0.1 |
||||||||||||
Income from operations before income taxes |
11.0 |
25.9 |
7.2 |
24.4 |
||||||||||||
Provision for income taxes |
3.0 |
4.5 |
1.8 |
4.2 |
||||||||||||
Net income |
8.0 |
% | 21.4 |
% | 5.4 |
% | 20.2 |
% | ||||||||
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
(dollars in millions) |
2019 |
2018 |
2019 |
2018 |
||||||||||||
Product |
$ | 401.3 |
$ | 510.0 |
$ | 798.7 |
$ | 1,006.7 |
||||||||
Service |
72.8 |
63.1 |
139.0 |
120.7 |
||||||||||||
Total net revenues |
$ | 474.1 |
$ | 573.1 |
$ | 937.7 |
$ | 1,127.4 |
||||||||
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
(dollars in millions) |
2019 |
2018 |
2019 |
2018 |
||||||||||||
Net revenues: |
||||||||||||||||
Vacuum & Analysis |
$ | 235.6 |
$ | 368.3 |
$ | 470.0 |
$ | 716.7 |
||||||||
Light & Motion |
182.6 |
204.8 |
376.6 |
410.7 |
||||||||||||
Equipment & Solutions |
55.9 |
— |
91.1 |
— |
||||||||||||
Total net revenues |
$ | 474.1 |
$ | 573.1 |
$ | 937.7 |
$ | 1,127.4 |
||||||||
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||||||||||
2019 |
2018 |
% Points Change |
2019 |
2018 |
% Points Change |
|||||||||||||||||||
Gross profit as a percentage of net revenues: |
||||||||||||||||||||||||
Product |
43.6 |
% | 47.7 |
% | (4.1 |
)% | 42.9 |
% | 47.5 |
% | (4.6 |
)% | ||||||||||||
Service |
49.3 |
50.3 |
(1.0 |
) | 47.8 |
49.1 |
(1.3 |
) | ||||||||||||||||
Total gross profit |
44.5 |
% | 48.0 |
% | (3.5 |
)% | 43.6 |
% | 47.7 |
% | (4.1 |
)% | ||||||||||||
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||||||||||
2019 |
2018 |
% Points Change |
2019 |
2018 |
% Points Change |
|||||||||||||||||||
Gross profit as a percentage of net revenues: |
||||||||||||||||||||||||
Vacuum & Analysis |
43.3 |
% | 46.4 |
% | (3.1 |
)% | 42.5 |
% | 46.0 |
% | (3.5 |
)% | ||||||||||||
Light & Motion |
45.7 |
50.7 |
(5.0 |
) | 46.8 |
50.7 |
(3.9 |
) | ||||||||||||||||
Equipment & Solutions |
44.5 |
— |
100.0 |
35.3 |
— |
100.0 |
||||||||||||||||||
Total gross profit |
44.5 |
% | 48.0 |
% | (3.5 |
)% | 43.6 |
% | 47.7 |
% | (4.1 |
)% | ||||||||||||
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
(dollars in millions) |
2019 |
2018 |
2019 |
2018 |
||||||||||||
Research and development expenses |
$ | 41.9 |
$ | 36.5 |
$ | 80.8 |
$ | 71.4 |
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
(dollars in millions) |
2019 |
2018 |
2019 |
2018 |
||||||||||||
Selling, general and administrative expenses |
$ | 83.2 |
$ | 76.2 |
$ | 165.7 |
$ | 159.1 |
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
(dollars in millions) |
2019 |
2018 |
2019 |
2018 |
||||||||||||
Fees and expenses related to term loan |
$ | — |
$ | 0.4 |
$ | 5.8 |
$ | 0.4 |
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
(dollars in millions) |
2019 |
2018 |
2019 |
2018 |
||||||||||||
Acquisition and integration costs |
$ | 3.2 |
$ | (1.2 |
) | $ | 33.4 |
$ | (1.2 |
) |
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
(dollars in millions) |
2019 |
2018 |
2019 |
2018 |
||||||||||||
Restructuring and other |
$ | 1.2 |
$ | 0.8 |
$ | 3.2 |
$ | 3.0 |
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
(dollars in millions) |
2019 |
2018 |
2019 |
2018 |
||||||||||||
Amortization of intangible assets |
$ | 17.6 |
$ | 10.9 |
$ | 33.3 |
$ | 22.1 |
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
(dollars in millions) |
2019 |
2018 |
2019 |
2018 |
||||||||||||
Interest expense, net |
$ | 11.3 |
$ | 2.5 |
$ | 18.7 |
$ | 6.8 |
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
(dollars in millions) |
2019 |
2018 |
2019 |
2018 |
||||||||||||
Other expense, net |
$ | 0.8 |
$ | 0.3 |
$ | 1.1 |
$ | 0.9 |
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
(dollars in millions) |
2019 |
2018 |
2019 |
2018 |
||||||||||||
Provision for income taxes |
$ | 14.1 |
$ | 25.7 |
$ | 17.0 |
$ | 47.3 |
ITEM 3. | QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK. |
ITEM 4. | CONTROLS AND PROCEDURES. |
ITEM 1. | LEGAL PROCEEDINGS. |
ITEM 1A. | RISK FACTORS. |
ITEM 6. | EXHIBITS. |
Exhibit No. |
Exhibit Description | |||
+3.1(1) |
||||
+3.2(2) |
||||
+3.3(3) |
||||
+3.4(4) |
||||
10.1 |
||||
*10.2 |
||||
31.1 |
||||
31.2 |
||||
32.1 |
||||
101.INS |
XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | |||
101.SCH |
XBRL Taxonomy Extension Schema Document | |||
101.CAL |
XBRL Taxonomy Extension Calculation Linkbase Document | |||
101.LAB |
XBRL Taxonomy Extension Label Linkbase Document | |||
101.PRE |
XBRL Taxonomy Extension Presentation Linkbase Document | |||
101.DEF |
XBRL Taxonomy Extension Definition Linkbase Document |
+ | Previously filed |
* | Management contract or compensatory plan arrangement |
(1) | Incorporated by reference to the Registration Statement on Form S-4 333-49738), |
(2) | Incorporated by reference to the Registrant’s Quarterly Report on Form 10-Q 000-23621), |
(3) | Incorporated by reference to the Registrant’s Quarterly Report on Form 10-Q 000-23621), |
(4) | Incorporated by reference to the Registrant’s Current Report on Form 8-K 000-23621), |
MKS INSTRUMENTS, INC. | ||||||
Date: August 7, 2019 |
By: |
/s/ Seth H. Bagshaw | ||||
Seth H. Bagshaw | ||||||
Senior Vice President, Chief Financial Officer and Treasurer | ||||||
(Principal Financial Officer) |
EXHIBIT 10.1
Execution Version
AMENDMENT NO. 1 TO ABL CREDIT AGREEMENT
This AMENDMENT NO. 1 TO ABL CREDIT AGREEMENT, dated as of April 26, 2019 (this Agreement), by and among MKS Instruments, Inc., a Massachusetts corporation (the Borrower), the other Loan Parties party hereto, Barclays Bank PLC (Barclays), as the administrative agent and the collateral agent (in such capacity, the Administrative Agent) under the Credit Agreement referred to below, and each Lender party hereto.
RECITALS:
WHEREAS, reference is made to the ABL Credit Agreement, dated as of February 1, 2019 and as amended, restated, amended and restated, supplemented or otherwise modified prior to the date hereof, the Existing Credit Agreement; and as amended by this Agreement, the Credit Agreement), among the Borrower, the other Borrowers from time to time party thereto, the Lenders and L/C Issuers from time to time party thereto and the Administrative Agent (capitalized terms used but not defined herein having the meaning provided in the Credit Agreement), pursuant to which the Lenders provided the Borrower with a senior secured asset-based revolving credit facility in the amount of $100,000,000;
WHEREAS, each Loan Party under the Existing Credit Agreement expects to realize substantial direct and indirect benefits as a result of this Agreement becoming effective and the consummation of the transactions contemplated hereby and agrees to reaffirm its obligations pursuant to the Credit Agreement, the Collateral Documents, and the other Loan Documents to which it is a party;
WHEREAS, the Borrower has requested that the Existing Credit Agreement be amended as set forth herein;
WHEREAS, the undersigned, constituting the Supermajority Lenders, are willing to agree to such amendments as set forth herein;
NOW, THEREFORE, in consideration of the premises and agreements, provisions and covenants herein contained, the parties hereto agree as follows:
1. | Credit Agreement Amendments. Effective as of the Amendment No. 1 Effective Date, the Existing Credit Agreement is hereby amended as follows: |
The definition of Borrowing Base in the Existing Credit Agreement is hereby amended and restated in its entirety as follows:
Borrowing Base means (a) the sum of 85% of Eligible Accounts of the Loan Parties; plus (b) either (i) with respect to any calculation conducted at any time prior to the completion of Administrative Agents and its third-party consultants and representatives initial field examination and appraisal of the Inventory of the Loan Parties after the Closing Date (it being understood that the Administrative Agent shall be permitted to conduct (or engage third parties to conduct) customary field examinations and inventory appraisals on the Inventory in its Permitted Discretion at any such time, and such initial field examination and inventory appraisal shall constitute a field examination and/or appraisal, as applicable, contemplated by Section 6.06(b)(i)), the lesser of (A) 20% of the net book value of Eligible Inventory of the Loan Parties located in the U.S. and (B) 30% of the Borrowing Base or (ii) with respect to any calculation conducted at any time thereafter, the lesser of (A) the lesser of (x) 65% of the lower of cost or market value (on a first-in-first-out basis) of Eligible Inventory of the Loan Parties and (y) 85% of the Net Orderly Liquidation Value of Eligible Inventory of the Loan Parties and (B) 30% of the Borrowing Base; minus (c) Reserves established by the Administrative Agent in the exercise of its Permitted Discretion. The Administrative Agent shall have the right, acting within the Administrative Agents Permitted Discretion, (x) to modify eligibility standards upon three (3) Business Days prior notice to MKS and (y) to establish and modify Reserves against the Borrowing Base upon three (3) Business Days prior notice to MKS (it being understood that on or after the third Business Day prior to the effectiveness of such establishment or modification, solely for purposes of incurring any new Credit Extension, the Borrowing Base shall be calculated after giving effect to such establishment or modification of Reserves).
In connection with any Post-Closing Acquisition, MKS may submit a Borrowing Base Certificate reflecting a calculation of the Borrowing Base that includes Eligible Accounts acquired in connection therewith (the Acquired Eligible Accounts) and, if Eligible Inventory has been included in the Borrowing Base pursuant to clause (b) of this definition above, Eligible Inventory acquired in connection therewith (the Acquired Eligible Inventory). From and after the Acquisition Date (as defined below), the Borrowing Base hereunder shall be calculated giving effect thereto; provided that prior to the occurrence of a Borrowing Base Examination with respect to such Acquired Eligible Accounts and Acquired Eligible Inventory, from the date such Post-Closing Acquisition is consummated (the Acquisition Date) until the date that is 60 days after the Acquisition Date, the aggregate amount of Acquired Eligible Accounts and Acquired Eligible Inventory included in the Borrowing Base prior to the completion of a Borrowing Base Examination with respect thereto shall not exceed 10% of the Borrowing Base (calculated after giving effect to the inclusion of the Acquired Eligible Accounts and Acquired Eligible Inventory as to which a Borrowing Base Examination has not occurred). From the 61st day following the Acquisition Date (or such later day as the Administrative Agent may agree) with respect to any applicable Acquired Eligible Accounts and Acquired Eligible Inventory, the Borrowing Base shall be calculated without reference to such Acquired Eligible Accounts and the Acquired Eligible Inventory until a Borrowing Base Examination has occurred with respect to such assets; it being understood and agreed that (x) no Default or Event of Default shall result from any failure for a Borrowing Base Examination with respect to Acquired Eligible Accounts or Acquired Eligible Inventory to occur on or prior to the dates indicated above and (y) any such Borrowing Base Examination with respect to Acquired Eligible Accounts or Acquired Eligible Inventory shall not count toward the limitations on the number of inventory appraisals and field examinations contained in Section 6.06(b).
4. | Effective Date Conditions. This Agreement will become effective on the date (the Amendment No. 1 Effective Date), on which each of the following conditions have been satisfied in accordance with the terms therein: |
(a) | Executed Amendment. The Administrative Agent (or its counsel) shall have received duly executed counterparts of this Agreement; |
(b) | Representations and Warranties. The representations and warranties of the Borrowers and the other Loan Parties contained in Article V of the Credit Agreement and in any other Loan Document shall be (i) in the case of representations and warranties qualified by materiality, Material Adverse Effect or similar language, true and correct in all respects on the date of hereof and (ii) in the case of all other representations and warranties, true and correct in all material respects, in each case, on and as of the date hereof, in each case, except to the extent that such representations and warranties specifically refer to an earlier date, in which case they shall be true and correct on the basis set forth above as of such earlier date; |
2
(c) | No Default. No Default or Event of Default shall have occurred and be continuing on the Amendment No. 1 Effective Date immediately after giving effect to this Amendment; and |
(d) | Payment of Fees. The Administrative Agent shall have received all fees and other amounts previously agreed to in writing by the Arrangers and the Borrower to be due on or prior to the Amendment No. 1 Effective Date, including, to the extent invoiced at least two (2) Business Days prior to the Amendment No. 1 Effective Date (or such later date as is reasonably agreed by the Borrower), legal fees and expenses and the fees and expenses of any other advisors in accordance with the terms of the Credit Agreement. |
5. | Representations and Warranties. By its execution of this Agreement, each Loan Party (and solely in the case of clause (d) below, each Borrower) hereby represents and warrants that: |
(a) | such Loan Party has all requisite corporate or other organizational power and authority to execute, deliver and perform its obligations under this Agreement; |
(b) | the execution, delivery and performance by such Loan Party of this Agreement (x) have been duly authorized by all necessary corporate, partnership, limited liability company or other organizational action, and (y) do not and will not (i) contravene the terms of any of such Loan Partys Organization Documents, (ii) conflict with or result in any breach or contravention of, or the creation of any Lien (other than Permitted Liens) under, any Contractual Obligation to which such Loan Party is a party or any order, injunction, writ or decree of any Governmental Authority or any arbitral award to which such Person or its property is subject except in the case of this clause (ii) any such conflict, breach or contravention that would not reasonably be expected individually or in the aggregate to have a Material Adverse Effect or (iii) violate any Law, except in any case for such violations that would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect; |
(c) | this Agreement has been duly executed and delivered by each Loan Party that is party hereto, and this Agreement constitutes a legal, valid and binding obligation of such Loan Party, enforceable against each Loan Party that is party thereto in accordance with its terms, except (i) as such enforceability may be limited by applicable bankruptcy, insolvency, examinership, reorganization, moratorium or similar laws affecting the enforcement of creditors rights generally and (ii) that rights of acceleration and the availability of equitable remedies may be limited by equitable principles of general applicability (regardless of whether enforcement is sought by proceedings in equity or at law); and |
(d) | both immediately before and after giving effect to the Amendment No. 1 Effective Date, (i) the representations and warranties of the Borrowers and the other Loan Parties contained in Article V of the Credit Agreement and in any other Loan Document shall be (A) in the case of representations and warranties qualified by materiality, Material Adverse Effect or similar language, true and correct in all respects on the date of hereof and (B) in the case of all other representations and warranties, true and correct in all material respects, in each case, on and as of the date hereof, in each case, except to the extent that such representations and warranties specifically refer to an earlier date, in which case they shall be true and correct on the basis set forth above as of such earlier date and (ii) no Default or Event of Default shall have occurred and be continuing. |
3
6. | Reaffirmation of the Loan Parties; Reference to and Effect on the Credit Agreement and the other Loan Documents. |
(a) | Each Loan Party hereby consents to the amendment of the Credit Agreement effected hereby and confirms and agrees that, notwithstanding the effectiveness of this Agreement, each Loan Document to which such Loan Party is a party is, and the obligations of such Loan Party contained in the Credit Agreement, this Agreement or in any other Loan Document to which it is a party are, and shall continue to be, in full force and effect and are hereby ratified and confirmed in all respects, in each case as amended by this Agreement. For greater certainty and without limiting the foregoing, each Loan Party hereby confirms that the existing security interests granted by such Loan Party in favor of the Senior Credit Parties pursuant to the Loan Documents in the Collateral described therein shall continue to secure the obligations of the Loan Parties under the Credit Agreement and the other Loan Documents as and to the extent provided in the Loan Documents. Except as specifically amended by this Agreement, the Credit Agreement and the other Loan Documents shall remain in full force. |
(b) | The execution, delivery and performance of this Agreement shall not constitute a waiver of any provision of, or operate as a waiver of any right, power or remedy of any Agent or Lender under, the Credit Agreement or any of the other Loan Documents. |
(c) | On and after the Amendment No. 1 Effective Date, each reference in the Credit Agreement to this Agreement, hereunder, hereof, herein or words of like import referring to the Credit Agreement, and each reference in the other Loan Documents to the Credit Agreement, thereunder, thereof or words of like import referring to the Credit Agreement shall mean and be a reference to the Credit Agreement as amended by this Agreement. |
7. | Amendment, Modification and Waiver. This Agreement may not be amended, modified or waived except as permitted by Section 10.01 of the Credit Agreement. |
8. | Integration. This Agreement constitute the entire contract among the parties relating to the subject matter hereof and supersede any and all previous agreements and understandings, oral or written, relating to the subject matter hereof. This Agreement shall not constitute a novation of any amount owing under the Existing Credit Agreement and all amounts owing in respect of principal, interest, fees and other amounts pursuant to the Existing Credit Agreement and the other Loan Documents shall, to the extent not paid or exchanged on or prior to the Amendment No. 1 Effective Date, continue to be owing under the Credit Agreement or such other Loan Documents until paid in accordance therewith. |
9. | Severability. The provisions of Section 10.12 of the Existing Credit Agreement are hereby incorporated by reference, mutatis mutandis, as if originally made a part hereof. |
10. | GOVERNING LAW; JURISDICTION; SERVICE OF PROCESS; WAIVER OF JURY TRIAL. THE PROVISIONS OF SECTION 10.13 OF THE CREDIT AGREEMENT ARE HEREBY INCORPORATED BY REFERENCE, MUTATIS MUTANDIS, AS IF ORIGINALLY MADE A PART HEREOF. |
4
11. | Counterparts. This Agreement may be executed in counterparts (and by different parties hereto in different counterparts), each of which shall constitute an original, but all of which when taken together shall constitute a single contract. Delivery of an executed counterpart of a signature page of this Agreement by telecopier shall be effective as delivery of a manually executed counterpart of this Agreement. |
12. | Loan Document. On and after the Amendment No. 1 Effective Date, this Agreement shall constitute a Loan Document for all purposes of the Credit Agreement and the other Loan Documents (it being understood that for the avoidance of doubt this Agreement may be amended or waived by the parties hereto solely as set forth in Section 7 above). |
[Signature Pages Follow]
5
IN WITNESS WHEREOF, each of the undersigned has caused its duly authorized officer to execute and deliver this Agreement as of the date first set forth above.
MKS INSTRUMENTS, INC. | ||||
By: | /s/ Seth H. Bagshaw | |||
Name: | Seth H. Bagshaw | |||
Title: | Senior Vice President, Chief Financial | |||
Officer and Treasurer | ||||
NEWPORT CORPORATION | ||||
By: | /s/ Seth H. Bagshaw | |||
Name: | Seth H. Bagshaw | |||
Title: | President and Treasurer | |||
ELECTRO SCIENTIFIC INDUSTRIES, INC. | ||||
By: | /s/ Seth H. Bagshaw | |||
Name: | Seth H. Bagshaw | |||
Title: | President and Treasurer | |||
ESI INTERNATIONAL CORPORATION | ||||
By: | /s/ Seth H. Bagshaw | |||
Name: | Seth H. Bagshaw | |||
Title: | President and Treasurer |
[Signature Page to First Amendment to ABL Credit Agreement]
ESI CHINA, INC. | ||||
By: | /s/ Seth H. Bagshaw | |||
Name: | Seth H. Bagshaw | |||
Title: | President and Treasurer | |||
ESI LEASING, LLC | ||||
By: | /s/ Kathleen F. Burke | |||
Name: | Kathleen F. Burke | |||
Title: | Manager |
[Signature Page to First Amendment to ABL Credit Agreement]
BARCLAYS BANK PLC, as Administrative Agent and as a Lender | ||||
By: | /s/ Komal Ramkirath | |||
Name: | Komal Ramkirath | |||
Title: | Assistant Vice President |
[Signature Page to First Amendment to ABL Credit Agreement]
BANK OF AMERICA, N.A., as a Lender | ||||
By: | /s/ Matthew T. OKeefe | |||
Name: | Matthew T. OKeefe | |||
Title: | Senior Vice President |
[Signature Page to First Amendment to ABL Credit Agreement]
HSBC BANK USA, NATIONAL ASSOCIATION, | ||||
as a Lender | ||||
By: | /s/ Manuel Burgueno | |||
Name: | Manuel Burgueno | |||
Title: | Senior Vice President |
[Signature Page to First Amendment to ABL Credit Agreement]
Exhibit 10.2
EMPLOYMENT AGREEMENT
MKS Instruments, Inc., a Massachusetts corporation (the Company), and Kathleen Burke of Winchester, MA (Employee) agree, effective August 1, 2016, as follows.
1. Employment. The Company is employing Employee on an at-will basis in the position of Senior Vice President, General Counsel and Assistant Secretary. Employee agrees to comply with the Companys policies.
2. Confidential Information Agreement. Employee will sign and deliver to the Company, at the same time that Employee executes this Employment Agreement, the Confidential Information, Intellectual Property and Non-Solicitation Agreement of MKS Instruments, Inc. (Confidential Information Agreement) that is Attachment 1 to this Employment Agreement.
3. Duty to The Company. While employed by the Company, Employee: (a) will devote his or her full working time and best efforts to the business of the Company; and (b) will not (without the prior, express, written consent of the Chief Executive Officer of the Company) engage in any business activity (whether or not for gain) that interferes with Employees work for the Company. Notwithstanding the previous sentence, this Employment Agreement does not prohibit Employee from managing his or her personal investments or engaging in charitable and unpaid professional activities (including serving on charitable and professional boards), so long as doing so does not materially interfere with Employees work for the Company or violate Section 7 of this Employment Agreement.
4. Compensation.
(a) Base Salary. The Company will pay Employee base salary at the rate of $350,000 per year (the Base Salary), in accordance with the Companys normal payroll practices. The Company may review and adjust the amount of the Base Salary from time to time in its sole discretion.
(b) Incentive Compensation Plan. Employee will be entitled to participate in the Companys Annual Corporate Management/Key Employee Bonus Plan, to the extent applicable to Employees position.
(c) Stock Incentive Plan. Employee will be entitled to participate in the Companys stock incentive plan to the extent applicable to Employees position.
(d) Benefits. Employee will be eligible to participate in the Companys generally available employee benefit plans, which currently include medical, dental, vision, life, accidental death and dismemberment, short-term disability and long-term disability insurance, a 401(k) savings plan and an employee stock purchase plan, subject to the terms and conditions of each plan.
(e) Paid Time Off. Employee will be eligible for 20 days of paid vacation per year, plus paid sick time and holidays, all subject to the terms and conditions of the Companys policies.
(f) Expenses. The Company will reimburse Employee for expenses Employee reasonably incurs in performing his or her duties, to the extent provided in the Companys expense reimbursement policies. Reimbursement of expenses in one tax year will not affect reimbursement of expenses in any other tax year.
5. End of Employment. Either Employee or the Company may end the employment relationship at any time, for any reason, with or without notice or cause. The employment relationship will end automatically and immediately upon Employees death or entitlement to long-term disability benefits under the Companys long-term disability program. The date on which Employees employment ends, whether as the result of a resignation by Employee, a termination of employment by the Company or an automatic termination of employment upon death or disability, is referred to in this Employment Agreement as the Employment End Date. If Employee resigns or the Company terminates Employees employment, the Company will (in either case) have the right at any time, for any reason in its sole discretion to decide the Employment End Date. In no event will the Companys deciding the Employment End Date following Employees resignation be considered termination by the Company of Employees employment.
6. Company Obligations Upon End of Employment. When the employment relationship ends, the Company will have no obligation to pay or provide Employee at any time any compensation, payment or benefit of any kind, except as expressly provided in Sections 6(a) though through 6(e) below.
(a) Minimum Obligations. When the employment relationship ends, no matter how it ends: (i) the Company will pay Employee any unpaid Base Salary through the Employment End Date; (ii) Employee will be entitled to accrued, vested benefits under the Companys benefit plans and programs to the extent provided in Section 4(d); (iii) the Company will pay Employee for any accrued but unused vacation; and (iv) the Company will reimburse Employee for any unreimbursed expenses incurred through the Employment End Date to the extent provided in Section 4(f).
(b) 30 Days Base Salary After Certain Resignations. If Employee provides the Company at least 30 days advance written notice of resignation of employment, is an active employee in good standing at the time of such notice and continues to perform his or her duties diligently and professionally to the extent requested thereafter, the Company will pay Employee his or her Base Salary for at least 30 days after such notice, even if the Employment End Date is earlier.
(c) 30 Days Base Salary After Certain Terminations. If the Company terminates Employees employment other than for Cause, as defined below, the Company will provide Employee with written notice of termination and pay Employee his or her Base Salary for at least 30 days after such notice of termination, even if the Employment End Date is earlier.
(d) Eligibility for Ordinary Severance Pay. If the Company terminates Employees employment, Employee will be eligible for severance pay in a lump sum in an amount equal to a minimum of 6 months of Base Salary or two weeks of Base Salary per year of service, whichever is greater, in either case provided that all of the following conditions are satisfied: (i) the Companys primary reason for terminating Employees employment was a change to the Companys business needs (such as reduction in force or elimination of position) and not Cause as defined below; (ii) Employee has complied with and continues to comply with all of Employees obligations under this Employment Agreement and the Confidential Information Agreement; and (iii) Employee executes, provides to the Company within 45 days after the Employment End Date and does not thereafter revoke or attempt to revoke, a general release of claims in a form satisfactory to the Company (General Release). The Companys good-faith determination that one or more of the conditions listed above has not been satisfied will be binding and conclusive.
2
(e) Eligibility for Enhanced Severance Compensation. Employee will become eligible for the Enhanced Severance Compensation, as described below, instead of severance pay under Section 6(d) above or under any other program or policy of the Company, if and only if all of the following conditions are satisfied: (i) the Company terminates Employees employment without Cause (as defined below) or Employee resigns for Good Reason (as defined below); (ii) the Employment End Date is within 24 months after the effective date of a Change in Control (as defined below); (iii) Employee has complied with and continues to comply with all of Employees obligations under this Employment Agreement and the Confidential Information Agreement; and (iv) Employee executes, provides to the Company within 45 days after the Employment End Date and does not thereafter revoke or attempt to revoke, a General Release. The Companys good-faith determination that one or more of the conditions listed above has not been satisfied will be binding and conclusive.
(f) Enhanced Severance Compensation. If Employee becomes eligible for the Enhanced Severance Compensation:
(i) Base Salary. The Company will pay Employee, within 14 days after the General Release become irrevocable, a lump sum in an amount equal to one and one half times annual Base Salary (determined without regard to any reduction in Base Salary giving rise to Good Reason, as defined below).
(ii) Incentive Compensation. The Company will pay Employee, within 14 days after the General Release becomes irrevocable, a lump sum equal to one and one half times the annual amount of incentive compensation for which Employee was eligible under any Incentive Compensation Plan of the Company then in effect for the year containing the Employment End Date. Additionally, the Employee will receive a payment for target bonus, prorated for the current year.
(iii) Continuation of Benefits. For a period of 18 months after the Employment End Date, to the extent Employee elects to continue group medical, vision, or dental insurance coverage under COBRA and timely remits the amount of premium assessed to similarly situated active employees for comparable coverage, the Company will pay the Companys usual share of such premiums. Benefits payable under this Section 6(f)(iii) will terminate to the extent Employee ceases to be eligible for COBRA coverage under the Companys medical benefits plan. Notwithstanding the foregoing, the Company will not pay the contribution toward COBRA coverage described above to the extent that the Company reasonably determines that doing so would subject the Company to the excise tax under Section 4980D of the Internal Revenue Code (the Code) (as a result of discriminatory coverage under a group health plan).
3
(iv) Restricted Stock Units or Stock Appreciation Rights. Employees unvested equity awards as of the Employment End Date will be subject to accelerated vesting to the extent provided in the respective equity award agreement issued to Employee under the then effective MKS Instruments, Inc. equity incentive plan (including the MKS Instruments, Inc. 2014 Stock Incentive Plan.
(vi) No Obligation to Mitigate Damages; Effect on Other Contractual Rights. Employee will not be required to mitigate damages or the amount of any payment provided for under this Employment Agreement by seeking other employment or otherwise, nor will any payment provided for under this Employment Agreement be reduced by any compensation earned by Employee as the result of employment by an employer other than the Company or a direct or indirect parent, subsidiary or affiliate of the Company after the Employment End Date, or otherwise.
(g) Cause. Cause to terminate Employees employment will exist if Employee:
(i) commits a felony or engages in fraud, misappropriation or embezzlement;
(ii) knowingly fails or refuses to perform Employees duties in a material way and, to the extent that the Company determines such failure or refusal can reasonably be cured, fails or refuses to effect a cure within 10 days after the Company notifies Employee in writing of the failure or refusal;
(iii) knowingly causes, or knowingly creates a serious risk of causing, material harm to the Companys business or reputation; or
(iv) breaches, in a material way, this Employment Agreement, the Confidential Information Agreement or any other agreement between Employee and the Company, and, to the extent that the Company determines such breach can reasonably be cured, fails or refuses to effect a cure within 10 days after the Company notifies Employee in writing of the breach.
(h) Good Reason. Good Reason for Employee to resign will exist if, without Employees express written consent:
(i) the Company materially reduces Employees position, duties or responsibilities;
(ii) the Company reduces Employees Base Salary as in effect on the date hereof or as the same may be increased from time to time during the term of this Employment Agreement;
4
(iii) the Company changes Employees principal place of work to a location more than 50 miles from Employees current principal place of work.
Notwithstanding the foregoing, an action described above will not constitute Good Reason unless: (A) Employee, within 30 days after the he or she learns, or with reasonable diligence should have learned, of such action, delivers to the Company written notice identifying the action as Good Reason and demanding its correction; (B) the Company fails to correct such event within 30 days after receipt of such notice; and (C) Employee resigns for Good Reason within 90 days after the date Employee learned, or with reasonable diligence should have learned, of such action.
(i) Change in Control. For purposes of this Employment Agreement, the term Change in Control will mean the first to occur of any of the following events: (i) any person (as that term is used in Section 13 and 14(d)(2) of the Securities Exchange Act of 1934 (Exchange Act)) becomes the beneficial owner (as that term is used in Section 13(d) of the Exchange Act), directly or indirectly, of fifty percent (50%) or more of MKS capital stock entitled to vote in the election of directors; (ii) the shareholders of MKS approve any consolidation or merger of MKS other than a consolidation or merger of MKS in which the holders of the common stock of MKS immediately prior to the consolidation or merger hold more than fifty percent (50%) of the common stock of the surviving corporation immediately after the consolidation or merger; or (iii) the shareholders of MKS approve the sale or transfer of all or substantially all of the assets of MKS to parties that are not within a controlled group of corporations (as defined in Code Section 1563) in which MKS is a member.
7. Non-Competition.
(a) During Employees MKS Employment (as defined below) and for 12 months immediately thereafter (together, the Non-Compete Period), Employee will not engage in or otherwise carry on, directly or indirectly anywhere in the world (as principal, agent, employee, employer, investor, shareholder (except for holdings of no greater than 1% of the total outstanding shares in a publicly-traded company), consultant, partner, member, manager, financier or in any other individual or representative capacity of any kind whatsoever), any Competitive Activity (as defined below).
(b) MKS Employment means the period beginning on the first day that Employee is employed by the Company and ending on the first day on which Employee is no longer employed by any MKS Entity (as defined below).
(c) MKS Entity means (i) the Company; (ii) any current or future parent, subsidiary or affiliate of the Company; or (iii) any successor or assign of (i) or (ii).
(d) Competitive Activity means business or activity competitive with an MKS Entity but only to the extent that business or activity is related to, similar to or competitive with the activities of the business unit(s), division(s), laborator(y)(ies), facilit(y)(ies) and other operational unit(s) in or for which Employee performed work for an MKS Entity or about which Employee acquired Proprietary Information (as defined in the Confidential Information Agreement).
5
(e) The Non-Compete Period will be extended for any period during which Employee is in breach of this Employment Agreement or the Confidential Information Agreement.
(f) If any court of competent jurisdiction determines that this Section 7 is unenforceable because the Non-Compete Period is too long or because Competitive Activity includes too great a range of activities or too wide a geographic scope, the parties agree that this Section 7 should be interpreted to extend only over the maximum period of time or range of activities or geographic scope as to which it may be enforceable.
(g) The post-employment restrictions on Employees conduct contained in this Employment Agreement and in the Confidential Information Agreement: (i) will continue to apply even if Employees duties, title, compensation, location or other terms or conditions of employment change, and even if such change or changes are material; and (ii) will apply regardless of how or why Employees employment ends.
(h) The Company and Employee agree that violation by Employee of any of the provisions of this Section 7 of this Employment Agreement would cause the Company irreparable harm beyond what could reasonably or adequately be compensated in damages, and that the Company would therefore be entitled (in addition to the Companys other remedies) to an injunction, declaratory judgment or restraining order against any such violation or threatened violation.
8. Code Section 409A Compliance.
(a) Where this Employment Agreement refers to Employees termination of employment for purposes of receiving any payment, whether such a termination has occurred will be determined in accordance with Section 409A of the Internal Revenue Code (the Code) and Treasury Regulation Section 1.409A-1(h) (or any successor provisions) to the extent required by law.
(b) To the extent that benefits under Section 6 are contingent upon Employee providing a General Release, Employee will sign and return the General Release within the reasonable time period designated by the Company, which will not be more than 45 days. If the period for Employee to review a General Release plus any revocation period crosses calendar years, payments contingent upon the Release will be made in the later calendar year. Any payments contingent upon the General Release that would otherwise be made during the period for review and revocation of the General Release will be made, provided that the General Release is timely executed and returned to the Company and not revoked, on the first scheduled payment date after such period ends. Each payment in respect of Employees termination of employment under Section 6 of the Employment Agreement is designated as a separate payment for Section 409A purposes.
(c) If Employee is designated as a specified Executive within the meaning of Code Section 409A (while the Company is publicly traded), any deferred compensation payment subject to Section 409A to be made during the six-month period following Employees termination of employment will be withheld and the amount of the payments withheld will be paid in a lump sum, without interest, during the seventh month after Employees termination; provided, however, that if Employee dies prior to the expiration of such six month period, payment to Employees beneficiary will be made as soon as reasonably practicable following Employees death. The Company will identify in writing delivered to Employee any payments it reasonably determines are subject to delay under this Section 8(c). In no event will the Company have any liability or obligation with respect to taxes for which Employee may become liable as a result of the application of Code Section 409A.
6
9. Code Sections 280G/4999. If (a) any payments or benefits to Employee in connection with this Employment Agreement (Payments) would be subject to the excise tax imposed by Code Section 4999 (the Parachute Tax), (b) paying Employee a lesser amount would avoid the Parachute Tax entirely and (c) payment of such lesser amount would, after taking into account applicable federal, state and local income taxes and the Parachute Tax, result in Employee receiving a greater after-tax payment than if the Company made the Payments in full, then the Company will pay Employee such lesser amount instead of making the Payments in full. The reporting and payment of any Parachute Tax will in all events be Employees responsibility. The Company will not in any event provide a gross-up or any other payment to compensate Employee for the payment of the Parachute Tax or for any reduction in the Payments. The Company will withhold from the Payments any amounts it reasonably determines are required under Code Section 4999(c) and the Treasury Regulations thereunder.
10. Withholding. The Company will deduct from the amounts payable to Employee pursuant to this Employment Agreement all withholding amounts and deductions required by law or authorized by Employee.
11. Changes to Plans and Policies. Nothing in this Employment Agreement will: (a) require the Company or its affiliates to establish, maintain or continue any incentive compensation plan, stock incentive plan or other benefit plan, policy or arrangement; (b) restrict the right of the Company or any of its affiliates to amend, modify or terminate any such plan, policy or arrangement; (c) entitle Employee to participate in any such plan policy or arrangement at any specified level (or at all) in any year; or (d) prevent any future change to any such plan, policy or arrangement from applying to Employee in accordance with the terms of the change.
12. Assignment. The rights and obligations of the Company under this Employment Agreement will inure to the benefit of, and be binding upon, the Companys successors and assigns. The rights and obligations of Employee under this Employment Agreement will inure to the benefit of, and will be binding upon, Employees heirs, executors and legal representatives. Employee may not delegate or assign any obligations under this Employment Agreement.
13. Entire Agreement and Severability. This Employment Agreement and the Confidential Information Agreement supersede any and all other agreements, either oral or in writing, between Employee and the Company with respect to the Companys employment of Employee. They contain all of the covenants and agreements between the parties with respect to such employment. Neither party is entering into this Employment Agreement on the basis of any representation, inducement, promise or agreement, oral or otherwise, by any party, or by any one acting on behalf of any party, which is not stated herein. Any modification of this Employment Agreement will be effective only if it is in writing and signed by both parties to this Employment Agreement. If any provision in this Employment Agreement is held by a court of competent jurisdiction to be invalid, void or unenforceable, the remaining provisions will nevertheless continue in full force and effect without being impaired or invalidated in any way.
7
14. Miscellaneous. This Employment Agreement and the rights and obligations of the parties hereunder will be governed by, and construed in accordance with, the laws of the Commonwealth of Massachusetts, excluding (but only to the extent permitted by law) its conflict of laws and choice of law rules. The parties agree that service of any process, summons, notice or document by U.S. certified mail or overnight delivery by a generally recognized commercial courier service to Employees last known address (or any mode of service recognized to be effective by applicable law) will be effective service of process for any action, suit or proceeding brought against Employee. The failure of either party hereto to enforce any right under this Employment Agreement will not be considered a waiver of that right, or of damages caused thereby, or of any other rights under this Employment Agreement.
15. Arbitration and Waiver of Jury Trial.
(a) Any Legal Dispute (as defined below) between Employee and any MKS Entity (or between Employee and any employee or agent of any MKS Entity, to the extent directly or indirectly arising from or relating in any way to Employees employment with or separation from the Company) will be resolved by final and binding arbitration. Notwithstanding the foregoing sentence, the Company may, in its sole discretion, obtain preliminary injunctive relief enforcing the provisions of the Confidential Information Agreement or Section 7 of this Employment Agreement from any court of competent jurisdiction.
(b) Legal Dispute means a dispute about legal rights or legal obligations, including but not limited to any rights or obligations arising under this Employment Agreement; the Confidential Information Agreement; any other agreement; any applicable legal or equitable doctrine; any applicable common law theory; or any applicable federal, state or local, statute, regulation or other legal requirement.
(c) The arbitration will be held in the Commonwealth of Massachusetts. It will be conducted in accordance with the then-prevailing Employment Arbitration Rules of the American Arbitration Association.
(d) Notwithstanding any other provision of this Employment Agreement or any other agreement or of any arbitration rules, no Legal Dispute involving any MKS Entity may be included in any class or collective arbitration or any other class or collective proceeding. The exclusive method for resolving any such Legal Dispute will be arbitration on an individual basis.
(e) Any issues about whether a dispute is subject to arbitration will be determined by a court of competent jurisdiction and not by an arbitrator. Any issues about the meaning or enforceability of Section 15(d) will be decided by a court of competent jurisdiction and not by an arbitrator.
8
(f) The Company, Employee and the arbitrator will treat all aspects of the arbitration proceedings, including without limitation, discovery, testimony and other evidence, briefs and the award, as strictly confidential, except that the arbitration award may be disclosed to the extent necessary to enforce the award, the provisions of the Confidential Information Agreement or the provisions of this Employment Agreement.
(g) Employee and the Company understand and acknowledge that by agreeing to arbitrate the disputes covered by this Section 15, they are waiving the right to resolve those disputes in court and waiving any right to a jury trial with respect to those disputes.
16. Knowing and Voluntary Agreement. Employee understands that Employee has the right to consult counsel before signing this Employment Agreement.
IN WITNESS WHEREOF, the parties hereto have executed, in the Commonwealth of Massachusetts, this Employment Agreement as a sealed instrument, all as of the day, month and year first written above.
MKS INSTRUMENTS, INC. | ||||||||||
By: | /s/ Gerald G. Colella |
Dated: | 8/11/16 |
|||||||
Name: | Gerald G. Colella |
|||||||||
Title: | CEO & President |
|||||||||
/s/ Kathleen F. Burke |
Dated: |
8-9-16 |
||||||||
[EMPLOYEE] |
9
Exhibit 10.2
AMENDMENT TO EMPLOYMENT AGREEMENT
This AMENDMENT (the Amendment) to the Employment Agreement is made this 29th day of October, 2018, by and between MKS Instruments, Inc., a Massachusetts corporation (MKS) and Kathleen Burke of Winchester, MA (Employee).
WHEREAS, MKS and Employee are parties to an employment agreement effective August 1, 2016 (the Employment Agreement); and
WHEREAS, MKS and Employee wish to modify certain provisions of the Employment Agreement relating to Employees eligibility for severance pay and benefits;
NOW THEREFORE, for good and valuable consideration, the sufficiency and receipt whereof are hereby acknowledged, the parties agree as follows:
1. In Section 6(d) of the Employment Agreement, the words a minimum of 6 months of Base Salary or two weeks of Base Salary per year of service, whichever is greater, in either case are deleted and replaced with the words 12 months of Base Salary.
2. In Section 6(d) of the Employment Agreement, the following new sentence is added immediately after the first sentence: If the Company terminates Employees employment and provided that all of the immediately foregoing conditions, (i)-(iii), are satisfied, the Company shall also continue to pay for any medical, dental and/or vision insurance that Employee elects to continue receiving under COBRA for twelve (12) months after the last full day Employee works prior to the effective date of Employees termination under this Employment Agreement, less the premium contribution paid by similarly-situated active employees who are enrolled in comparable coverage.
3. Except as modified in paragraphs 1 and 2 above, the Employment Agreement shall remain unchanged. To avoid any doubt and without limitation of any kind, the parties acknowledge and agree that this Amendment is not intended to, and shall not, have any effect on Employees obligations under Section 7 of the Employment Agreement, notwithstanding the enactment of Section 24L of Chapter 149 of the Massachusetts General Laws or any other change in the law after the parties entered into the Employment Agreement. To ensure that MKSs ability to enforce the post-employment restrictions set forth in Section 7 of the Employment Agreement is in no way diminished by the parties entering into this Amendment, Employee agrees that MKS may (if it deems advisable in its sole discretion) add to the General Release referred to in Section 6(d) of the Employment Agreement post-employment restrictions identical to the post-employment restrictions set forth in Section 7 of the Employment Agreement.
In witness whereof, the parties hereto have executed, in the Commonwealth of Massachusetts, this Amendment as a sealed instrument, as of the date first written above.
MKS INSTRUMENTS, INC. | ||
By: | Catherine M. Langtry | |
SVP HR | ||
/s/ Kathleen F. Burke | ||
Kathleen Burke |
EXHIBIT 31.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO RULE 13a-14(a)/RULE 15d-14(a) OF THE
SECURITIES EXCHANGE ACT OF 1934, AS AMENDED
I, Gerald G. Colella, certify that:
1. | I have reviewed this Quarterly Report on Form 10-Q of MKS Instruments, Inc.; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrants other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c) | Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d) | Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and |
5. | The registrants other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions): |
a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and |
b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting. |
Date: August 7, 2019 | /s/ Gerald G. Colella | |||||
Gerald G. Colella | ||||||
Chief Executive Officer | ||||||
(Principal Executive Officer) |
EXHIBIT 31.2
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
PURSUANT TO RULE 13a-14(a)/RULE 15d-14(a) OF THE
SECURITIES EXCHANGE ACT OF 1934, AS AMENDED
I, Seth H. Bagshaw, certify that:
1. | I have reviewed this Quarterly Report on Form 10-Q of MKS Instruments, Inc.; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrants other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c) | Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d) | Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and |
5. | The registrants other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions): |
a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and |
b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting. |
Date: August 7, 2019 | /s/ Seth H. Bagshaw | |||||
Seth H. Bagshaw | ||||||
Senior Vice President, Chief Financial Officer and Treasurer | ||||||
(Principal Financial Officer) |
EXHIBIT 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of MKS Instruments, Inc. (the Company) for the period ended June 30, 2019, as filed with the Securities and Exchange Commission on the date hereof (the Report), the undersigned, Gerald G. Colella, Chief Executive Officer of the Company, and Seth H. Bagshaw, Senior Vice President, Chief Financial Officer and Treasurer of the Company, each hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, based on his knowledge:
(1) | the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Dated: August 7, 2019 | /s/ Gerald G. Colella | |||||
Gerald G. Colella | ||||||
Chief Executive Officer | ||||||
Dated: August 7, 2019 | /s/ Seth H. Bagshaw | |||||
Seth H. Bagshaw | ||||||
Senior Vice President, Chief Financial Officer and Treasurer |